342 filings
Page 2 of 18
8-K
mrvd sbk6y
10 Oct 23
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
8:02am
CORRESP
ci0vkofk9kfc kl
6 Oct 23
Correspondence with SEC
12:00am
8-K
blxen
26 Sep 23
Pacira BioSciences Announces Leadership Succession Plan
4:32pm
UPLOAD
wyk9jq
22 Sep 23
Letter from SEC
12:00am
8-K
8xbe2m7w
11 Sep 23
Other Events
4:27pm
S-8
3ic0tbog69xkw8c93i
2 Aug 23
Registration of securities for employees
4:34pm
8-K
ana 2y41mcu7rpx8
2 Aug 23
Pacira BioSciences Reports Second Quarter 2023 Financial Results
8:02am
8-K
f09dsy0 76f5l5x
20 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
utsemb4
3 May 23
Pacira BioSciences Reports First Quarter 2023 Financial Results
8:02am
ARS
sqs3mpxkffkgb10
21 Apr 23
Annual report to shareholders
4:12pm
DEFA14A
8xuyo
21 Apr 23
Additional proxy soliciting materials
4:08pm
8-K
dkvv90h86jre3honfwc1
3 Apr 23
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using
8:02am
8-K
bubjf7t4l
22 Mar 23
Pacira BioSciences Announces Departure of Yvonne Greenstreet from Board of Directors
8:01am
8-K
wv0w1p
28 Feb 23
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
8:03am
8-K
6oepywofkkbjlemo
5 Jan 23
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
4:31pm
8-K
ldrtcs6l2l1je bg
13 Dec 22
Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022
8:02am